Dong Lin

Active 1993–2026

Also published as
Dong, Lin
280
Papers
18,853
Citations
70
h-index
201
i10-index

Citations

Citations per year for Dong Lin1984: 1 citations1993: 2 citations1994: 8 citations1995: 42 citations1996: 45 citations1997: 77 citations1998: 52 citations1999: 87 citations2000: 85 citations2001: 106 citations2002: 111 citations2003: 125 citations2004: 142 citations2005: 116 citations2006: 90 citations2007: 108 citations2008: 97 citations2009: 61 citations2010: 97 citations2011: 72 citations2012: 68 citations2013: 72 citations2014: 85 citations2015: 128 citations2016: 186 citations2017: 174 citations2018: 240 citations2019: 462 citations2020: 615 citations2021: 772 citations2022: 627 citations2023: 532 citations2024: 723 citations2025: 460 citations2026: 78 citations2027: 1 citations1985–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,190 citing papers, 26% of this breakdownChina: 1,849 citing papers, 22% of this breakdownCanada: 419 citing papers, 5% of this breakdownUnited Kingdom: 402 citing papers, 4.8% of this breakdownGermany: 257 citing papers, 3% of this breakdownIndia: 231 citing papers, 2.7% of this breakdownItaly: 231 citing papers, 2.7% of this breakdownFrance: 220 citing papers, 2.6% of this breakdownJapan: 217 citing papers, 2.6% of this breakdownAustralia: 201 citing papers, 2.4% of this breakdownSouth Korea: 140 citing papers, 1.7% of this breakdownSwitzerland: 136 citing papers, 1.6% of this breakdown
0%26%Other 22.9%

Fields

  • Medicine28.4%
  • Computer Science28.3%
  • Biochemistry, Genetics and Molecular Biology22.9%
  • Engineering7%
  • Immunology and Microbiology4.1%
  • Neuroscience1.6%
  • Other7.7%

Topics

  • Network Traffic and Congestion Control4.7%
  • Prostate Cancer Treatment and Research3.2%
  • Software-Defined Networks and 5G2.8%
  • Cancer Genomics and Diagnostics1.8%
  • Cancer-related molecular mechanisms research1.7%
  • Cancer Cells and Metastasis1.5%
  • Other84.3%

Coauthors

All papers

Open in search
  1. DCN-M: Improved Deep & Cross Network for Feature Cross Learning in Web-scale Learning to Rank Systems

    Authors: , , , , , , - Web Conference 2021, WWW 2021 cited by 507

  2. The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Discovery 2016 cited by 444

  3. Understanding and Improving Knowledge Distillation

    Authors: , , , , , , - arXiv (Cornell University), CoRR 2020 cited by 130

  4. ONECUT2 is a driver of neuroendocrine prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felix Y. Feng, Leigh Ellis, Theodorus van der Kwast, Alejandro Berlín, Marianne Koritzinsky, Paul C. Boutros, Amina Zoubeidi, Himisha Beltran, Yuzhuo Wang, Housheng Hansen He - Nature Communications 2019 cited by 244

  5. Deep learning-based automated detection for diabetic retinopathy and diabetic macular oedema in retinal fundus photographs

    Authors: , , , , , , , , , - Eye 2021 cited by 152

  6. Molecular events in neuroendocrine prostate cancer development

    Authors: , , , , , , - Nature Reviews Urology 2021 cited by 188

  7. Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial

    Authors: , , , , , , , , , - Brain stimulation 2022 cited by 91

  8. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2017 cited by 301

  9. Cell–cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models

    Authors: , , , , , , , , , , , - Cellular and Molecular Immunology 2019 cited by 236

  10. Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

    Authors: , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 89

  11. SIRT1 and HIF1α signaling in metabolism and immune responses

    Authors: , , , - Cancer Letters 2018 cited by 150

  12. POLE/POLD1 mutation and tumor immunotherapy

    Authors: , , , , - Journal of Experimental & Clinical Cancer Research 2022 cited by 130

  13. A noncanonical AR addiction drives enzalutamide resistance in prostate cancer

    Authors: , , , , , , , , , , , , , , - Nature Communications 2021 cited by 90

  14. Interleaved Reasoning for Large Language Models via Reinforcement Learning

    Authors: , , , , , , , - ArXiv.org, CoRR 2025 cited by 21

  15. High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2013 cited by 365

  16. Regulations of Glycolytic Activities on Macrophages Functions in Tumor and Infectious Inflammation

    Authors: , , , , , , , , , , - Frontiers in Cellular and Infection Microbiology 2020 cited by 91

  17. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hongwei Cheng, Hui Xue, Yuzhuo Wang, Dong Lin, Andrew J. Mungall, Richard A. Moore, Yongjun Zhao, Julie Lorette, Long Nguyen, David G. Huntsman, Connie J. Eaves, Carl L. Hansen, Marco A. Marra, Carlos Caldas, Sohrab P. Shah, Samuel Aparício - Nature 2014 cited by 642

  18. The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2015 cited by 301

  19. Process Optimization, Structural Characterization, and Calcium Release Rate Evaluation of Mung Bean Peptides-Calcium Chelate

    Authors: , , , , , , - Foods 2023 cited by 40

  20. Developing a deep reinforcement learning model for safety risk prediction at subway construction sites

    Authors: , , , , , - Reliability Engineering & System Safety, Reliab. Eng. Syst. Saf. 2025 cited by 46

  21. The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , - EMBO Molecular Medicine 2019 cited by 90

  22. Construction safety management in the data-rich era: A hybrid review based upon three perspectives of nature of dataset, machine learning approach, and research topic

    Authors: , , , , , , - Advanced Engineering Informatics, Adv. Eng. Informatics 2023 cited by 34

  23. Transport and Mobility Needs for an Ageing Society from a Policy Perspective: Review and Implications

    Authors: , - International Journal of Environmental Research and Public Health 2021 cited by 91

  24. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yinghao Sun, Yuzhuo Wang, Colin C. Collins, Yuzhuo Wang, Colin C. Collins - European Urology 2017 cited by 78